Endocrine and Bone Complications in β-Thalassemia Intermedia: Current Understanding and Treatment
Thalassemia intermedia (TI), also known as nontransfusion dependent thalassemia (NTDT), is a type of thalassemia where affected patients do not require lifelong regular transfusions for survival but may require occasional or even frequent transfusions in certain clinical settings and for defined per...
Main Authors: | Adlette Inati, MohammadHassan A. Noureldine, Anthony Mansour, Hussein A. Abbas |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2015/813098 |
Similar Items
-
Beta-Thalassaemia Intermedia: Evaluation of Endocrine and Bone Complications
by: M. Baldini, et al.
Published: (2014-01-01) -
Endocrine complications in patients with major β-thalassemia
by: Parastoo Rostami, et al.
Published: (2011-11-01) -
Hypothyroidism in β-Thalassemia Intermedia Patients with and without Hydroxyurea
by: Omid Reza Zekavat, et al.
Published: (2014-01-01) -
Clinical and Haematological Effects of Hydroxyurea in β-Thalassemia Intermedia Patients
by: Bijan Keikhaei, et al.
Published: (2015-10-01) -
EARLY PREDICTORS OF RENAL DYSFUNCTION IN Β-THALASSEMIA MAJOR AND INTERMEDIA PATIENTS
by: Azza A.G. Tantawy, et al.
Published: (2004-09-01)